北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 基础医学院  > 细胞生物学系  > 期刊论文
学科主题: 基础医学
题名:
LAPTM4B-35 Is a Novel Prognostic Factor of Hepatocellular Carcinoma
作者: Yang, Hua1; Xiong, Fuxia1; Qi, Ruizhao2; Liu, Zhenwen2; Lin, Ming1; Rui, Jingan2; Su, Jing3; Zhou, Rouli1
关键词: lysosomal protein transmembrane 4 beta (LAPTM4B) ; Western blot ; immunohistochemistry (IHC) ; hepatocellular carcinoma (HCC) ; prognosis
刊名: JOURNAL OF SURGICAL ONCOLOGY
发表日期: 2010-04-01
DOI: 10.1002/jso.21489
卷: 101, 期:5, 页:363-369
收录类别: SCI
文章类型: Article
WOS标题词: Science & Technology
类目[WOS]: Oncology ; Surgery
研究领域[WOS]: Oncology ; Surgery
关键词[WOS]: LIVER-DISEASE ; PHASE-II ; CANCER ; EXPRESSION ; SORAFENIB ; ERLOTINIB ; RESECTION ; THERAPY ; PROTEIN ; MARKER
英文摘要:

Background: LAPTM4B-35 is a 35-kDa tetra-transmembrane protein overexpressed in hepatocellular carcinoma (HCC) and promotes cell survival, proliferation, and tumorigenesis. However, the potential clinical implications of LAPTM4B-35 in HCC are still unclear. This study is aimed to investigate the correlations between LAPTM4B-35 expression and prognosis in patients with HCC.

Methods: Western blot and immunohistochemistry assays were used to determine the expression of LAPTM4B-35 in HCCs and their paired noncancerous liver tissues from 65 patients. The correlations of LAPTM4B-35 expression with clinicopathological parameters were assessed by Chi-square test. Patient survival was determined by Kaplan-Meier method and log-rank test. Cox regression was adopted for multivariate analysis of prognostic factors.

Results: LAPTM4B-35 overexpression occurred in 76.9% of HCC tissues, while only in 4.6% of noncancerous liver tissues. Overexpression of LAPTM4B-35 was significantly associated with TNM staging and invasive tumors. Patients with higher LAPTM4B-35 expression had significantly poorer overall survival (OS) and disease-free survival (DFS) (both P < 0.001). On multivariate analysis, elevated expression of LAPTM4B-35 was found to be an independent prognostic factor for OS and DFS (P = 0.009, 0.043, respectively).

Conclusions: LAPTM4B-35 overexpression is an independent prognostic factor for OS and DFS of HCC. J. Surg. Oncol. 2010;101:363-369. (C) 2010 Wiley-Liss, Inc.

语种: 英语
所属项目编号: H020220020310 ; 7041003
项目资助者: special fund for promotion of education, Ministry of Education ; 248 major R&amp ; D program of Beijing ; Natural Science Foundation of Beijing
WOS记录号: WOS:000276858500004
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/60419
Appears in Collections:基础医学院_细胞生物学系_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: 1.Peking Univ, Dept Cell Biol, Sch Basic Med Sci, Beijing 100191, Peoples R China
2.302 Hosp Peoples Liberat Army, Dept Liver & Gallbladder Surg, Beijing, Peoples R China
3.Peking Univ, Dept Pathol, Sch Basic Med Sci, Beijing 100191, Peoples R China

Recommended Citation:
Yang, Hua,Xiong, Fuxia,Qi, Ruizhao,et al. LAPTM4B-35 Is a Novel Prognostic Factor of Hepatocellular Carcinoma[J]. JOURNAL OF SURGICAL ONCOLOGY,2010,101(5):363-369.
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Yang, Hua]'s Articles
[Xiong, Fuxia]'s Articles
[Qi, Ruizhao]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Yang, Hua]‘s Articles
[Xiong, Fuxia]‘s Articles
[Qi, Ruizhao]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace